Literature DB >> 12584052

C5 is required for CD49d expression on neutrophils and VCAM expression on vascular endothelial cells following mesenteric ischemia/reperfusion.

Sherry D Fleming1, Jimie Anderson, Felisa Wilson, Terez Shea-Donohue, George C Tsokos.   

Abstract

Complement activation is critical in the development of local mucosal damage and inflammation as well as of remote organ injury after mesenteric ischemia/reperfusion. To further define the role of C5 activation in local and remote tissue injury, C5 deficient (C5(-/-)) and wild-type control (C5(+/+)) mice treated with an anti-C5 mAb were subjected to sham or ischemia followed by up to 4 h of reperfusion. The development of local (intestinal) and remote (lung) injury was associated with the expression of CD49d on the surface of circulating blood neutrophils and with VCAM on the endothelial cells of intestinal and lung vessels. Because CD49d heterodimerizes with integrin beta1 on the surface of neutrophils and can bind VCAM on the endothelium, we propose that complement activation causes organ damage by upregulating molecules that lead to inappropriate homing of neutrophils.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12584052     DOI: 10.1016/s1521-6616(02)00021-9

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  9 in total

1.  A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response.

Authors:  Kerry J Welsh; April N Abbott; Shen-An Hwang; Jessica Indrigo; Lisa Y Armitige; Michael R Blackburn; Robert L Hunter; Jeffrey K Actor
Journal:  Microbiology (Reading)       Date:  2008-06       Impact factor: 2.777

2.  Spleen tyrosine kinase inhibition prevents tissue damage after ischemia-reperfusion.

Authors:  Omer Nuri Pamuk; Peter H Lapchak; Poonam Rani; Polly Pine; Jurandir J Dalle Lucca; George C Tsokos
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-06-03       Impact factor: 4.052

3.  Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection.

Authors:  Carl Atkinson; Hongbin Song; Bo Lu; Fei Qiao; Tara A Burns; V Michael Holers; George C Tsokos; Stephen Tomlinson
Journal:  J Clin Invest       Date:  2005-08-25       Impact factor: 14.808

4.  Domain V peptides inhibit beta2-glycoprotein I-mediated mesenteric ischemia/reperfusion-induced tissue damage and inflammation.

Authors:  Sherry D Fleming; Michael R Pope; Sara M Hoffman; Tiffany Moses; Urska Bukovnik; John M Tomich; Lynn M Wagner; Keith M Woods
Journal:  J Immunol       Date:  2010-10-18       Impact factor: 5.422

5.  Elimination of C5aR prevents intestinal mucosal damage and attenuates neutrophil infiltration in local and remote organs.

Authors:  Da-Zhong Xu; Sergey B Zaets; Ruihua Chen; Qi Lu; Harini Rajan; Xiaoman Yang; John Zhang; Eleonora Feketova; Nancy Bogdan; Edwin A Deitch; Yang Cao
Journal:  Shock       Date:  2009-05       Impact factor: 3.454

6.  Complement component C5a mediates hemorrhage-induced intestinal damage.

Authors:  Sherry D Fleming; Lauren M Phillips; John D Lambris; George C Tsokos
Journal:  J Surg Res       Date:  2008-03-13       Impact factor: 2.192

7.  Platelet-associated CD40/CD154 mediates remote tissue damage after mesenteric ischemia/reperfusion injury.

Authors:  Peter H Lapchak; Antonis Ioannou; Lakshmi Kannan; Poonam Rani; Jurandir J Dalle Lucca; George C Tsokos
Journal:  PLoS One       Date:  2012-02-27       Impact factor: 3.240

8.  The tripeptide feG regulates the production of intracellular reactive oxygen species by neutrophils.

Authors:  Ronald D Mathison; Joseph S Davison
Journal:  J Inflamm (Lond)       Date:  2006-06-15       Impact factor: 4.981

9.  Annexin-A1 peptide down-regulates the leukocyte recruitment and up-regulates interleukin-10 release into lung after intestinal ischemia-reperfusion in mice.

Authors:  Bruna Candido Guido; Marianna Zanatelli; Wothan Tavares-de-Lima; Sonia Maria Oliani; Amílcar Sabino Damazo
Journal:  J Inflamm (Lond)       Date:  2013-03-13       Impact factor: 4.981

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.